StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.1
  1. Startseite
  2. /Verbindung

Bleidibromid

Lead (II) bromide

HCID 24831
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
10031-22-8
Standard-SMILES
[Br][Pb][Br]
InChIKey
ZASWJUOMEGBQCQ-UHFFFAOYSA-L
Summenformel
Br2Pb
Durchschnittliche Molmasse
367 g/mol
Monoisotopische Masse
365,81333

Überblick

Lead bromide is a bromide of lead. Lead is a heavy metal and stable element with the symbol Pb and the atomic number 82, existing in metallic, organic, and inorganic forms. It is mainly found in nature as the mineral galena (PbS), cerussite (PbCO3) or anglesite (PbSO4), usually in ore with zinc, silver, or copper. Bromine is a halogen element with the symbol Br and atomic number 35. Diatomic bromine does not occur naturally, but bromine salts can be found in crustal rock. (L625, L21)

Namen und Bezeichner

Bevorzugter Name
Lead (II) bromide
IUPAC
dibromolead
Lokaler Name
Bleidibromid
Englischer Name
LEAD(II) BROMIDE
Summenformel
Br2Pb
Molmasse
367.01

Namen und Synonyme

Lead (II) bromideRefChem:798696Lead(II) bromideLead dibromidePbBr2CCRIS 4220EINECS 233-084-4leadbromideUNII-1O767M99U7Lead(II) bromide, ultra drySCHEMBL108657Lead(II) bromide, >=98%
Weitere Namen anzeigen
LEAD BROMIDE398853-5GdibromoleadSuper PbBr2BleidibromidLEAD(+2)BROMIDELead Bromide 99%
Lead(II) bromide, Puratronic?LEAD (II) BROMIDE, ANHYDROUSAKOS01590379912646-11-6CS-0416204Lead(II) bromide, 99.999% trace metals basisQ425231Lead(II) bromide, anhydrous, beads, -10 mesh, 99.999%

Datenbank-Bezeichner

CAS
10031-22-8
PubChem CID
24831
EC Number
233-084-4

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
0 Ų
H-Brücken-Donoren
0
H-Brücken-Akzeptoren
0
Frei drehbare Bindungen
0
Schwere Atome
3
Formalladung
0
Komplexität
2,8

Experimentelle und physikochemische Eigenschaften

Chemical ClassesMetals -> Lead Compounds, Inorganic
SpringerMaterials Propertiesdielectric constant
Physical DescriptionWhite solid; [Merck Index]

Physikochemische Eigenschaften

Schmelzpunkt
371 °C · 371 °C(lit.)
Siedepunkt
892 °C · 892 °C(lit.)
Dichte
6.66 g/mL · 6.66 g/mL at 25 °C(lit.)
storage temp.
Keep in dark place,Inert atmosphere,Room temperature
Löslichkeit
ethanol: insoluble(lit.)
Aggregatzustand
Powder
Wichte
6.66 · 6.66
Farbe
White to off-white
Wasserlöslichkeit
20 °C · Soluble in water at 20°C 5g/L. Insoluble in ethanol. Solubility in N,N-DMF is almost transparent.
Spezifische Wärmekapazität

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Danger

H302 (97.9%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P260, P261, P264, P270, P271, P273, P280, P301+P317, P304+P340, P317, P318, P319, P330, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 48 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory InformationRestricted substance: Lead dibromide
Hazards SummaryToxic by inhalation; [Hawley] See Bromine. See Lead and linked occupational diseases.
Hazard Classes and CategoriesAcute Tox. 4 (97.9%)

Sicherheit und Schutzausrüstung

Exposure Control and Personal ProtectionBiological Exposure Indices (BEI) [ACGIH] - Lead in blood = 200 ug/L (20 ug/100 ml); sampling time not critical; [ACGIH]
Minimum Risk LevelChronic Inhalation: 0.05 mg/m3 (Lead) (L134)
Threshold Limit Values (TLV)0.05 [mg/m3], as Pb
Permissible Exposure Limit (PEL)0.05 [mg/m3], as Pb

Toxikologische Informationen

Chemie und Industrie

Pharmakologische Informationen

Metabolism/Metabolites · 1 Eintrag

Lead is absorbed following inhalation, oral, and dermal exposure. It is then distributed mainly to the bones and red blood cells. In the blood lead may be found bound to serum albumin or the metal-binding protein metallothionein. Organic lead is metabolized by cytochrome P-450 enzymes, whereas inorganic lead forms complexes with delta-aminolevulinic acid dehydratase. Lead is excreted mainly in the urine and faeces. Bromine is mainly absorbed via inhalation, but may also enter the body through dermal contact. Bromine salts can be ingested. Due to its reactivity, bromine quickly forms bromide and may be deposited in the tissues, displacing other halogens. (L626, L136)

Verwendung und Herstellung

Uses · 2 Einträge

Used as a catalyst to make polyesters, a filler for polypropylene (flame-resistant), and in glass optical waveguides; [[Ullmann]

No data.

Anwendungen · 1 Eintrag

VerwendenIt is used in the field of antirust, pigment and photograph. The molten lead(II) bromide acts as an electrolyte. Lead(II) bromide provides a high concentration of lead(II) ions and bromide ions to carry the current during the electrolysis process. The rare-earth-doped alkali-lead bromide crystals (potassium lead bromide (or) KPB; rubidium lead bromide or RPB) emerge as promising new low-phonon-energy host materials for mid-IR applications and are useful for solid state lasers. Hybrid organic/lead halide perovskites are promising materials for solar cell fabrication.

Zugehörige Reaktionen

13
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 125341
HRID 125341als EduktTraining data from https://doi.org/10.1039/C8SC04228D (2/10)
Reaktionsgleichung von HRID 172098
HRID 172098als EduktTraining data from https://doi.org/10.1039/C8SC04228D (9/10)
Reaktionsgleichung von HRID 290050
HRID 290050als EduktTraining data from https://doi.org/10.1039/C8SC04228D (8/10)
Reaktionsgleichung von HRID 695033
HRID 695033als EduktTraining data from https://doi.org/10.1039/C8SC04228D (3/10)
Reaktionsgleichung von HRID 1538756
HRID 1538756als EduktTraining data from https://doi.org/10.1039/C8SC04228D (1/10)
Reaktionsgleichung von HRID 1957488
HRID 1957488als Eduktuspto-grants-1998_07
Reaktionsgleichung von HRID 1960094
HRID 1960094als Eduktuspto-grants-2013_04
Reaktionsgleichung von HRID 1960095
HRID 1960095als Eduktuspto-grants-2013_04
ZurückSeite 1 von 2

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
0.22 J/ · Cp(crystal): 0.22 J/(g·K), at 25℃
Merck
14 · 14,5403
Stabilität
Stable.
InChI
1S/2BrH.Pb/h2*1H;/q;;+2/p-2
InChIKey
ZASWJUOMEGBQCQ-UHFFFAOYSA-L
SMILES
Br[PbH2]Br
CAS Datenbank
10031 · 10031-22-8(CAS DataBase Reference)
EPA chemische Informationen
Lead(II) bromide (10031-22-8)
Treatment · 1 Eintrag

Lead poisoning is usually treated with chelation therapy using DMSA, EDTA, or dimercaprol. Bromine should be washed with water from any areas of dermal or ocular contact. If inhaled, treatment is mainly symptomatic and may include maintaining an adequate airway, administering oxygen, antibronchospasm therapy, and/or antibiotics. (L626, L21)

Health Effects · 1 Eintrag

Lead is a neurotoxin and has been known to cause brain damage and reduced cognitive capacity, especially in children. Lead exposure can result in nephropathy, as well as blood disorders such as high blood pressure and anemia. Lead also exhibits reproductive toxicity and can results in miscarriages and reduced sperm production. Bromine vapour causes irritation and direct damage to the mucous membranes. Elemental bromine also burns the skin. The bromide ion is a central nervous system depressant and chronic exposure produces neuronal effects. This is called bromism and can result in central reactions reaching from somnolence to coma, cachexia, exicosis, loss of reflexes or pathologic reflexes, clonic seizures, tremor, ataxia, loss of neural sensitivity, paresis, papillar edema of the eyes, abnormal speech, cerebral edema, delirium, aggressiveness, and psychoses. (L625, L626, L627, L21)

Adverse EffectsNeurotoxin - Predominantly motor
Exposure RoutesOral (L136) ; inhalation (L136); dermal (L136)
Toxicity Summary · 1 Eintrag

Lead mimics other biologically important metals, such as zinc, calcium, and iron, competing as cofactors for many of their respective enzymatic reactions. For example, lead has been shown to competitively inhibit calcium's binding of calmodulin, interferring with neurotransmitter release. It exhibits similar competitive inhibition at the NMDA receptor and protein kinase C, which impairs brain microvascular formation and function, as well as alters the blood-brain barrier. Lead also affects the nervous system by impairing regulation of dopamine synthesis and blocking evoked release of acetylcholine. However, it's main mechanism of action occurs by inhibiting delta-aminolevulinic acid dehydratase, an enzyme vital in the biosynthesis of heme, which is a necesssary cofactor of hemoglobin. Bromine is a powerful oxidizing agent and is able to release oxygen free radicals from the water in mucous membranes. These free radicals are also potent oxidizers and produce tissue damage. In additon, the formation of hydrobromic and bromic acids will result in secondary irritation. The bromide ion is also known to affect the central nervous system, causing bromism. This is believed to be a result of bromide ions substituting for chloride ions in the in actions of neurotransmitters and transport systems, thus affecting numerous synaptic processes. (L626, L627, A543, T4, A20, A22, L136)

Signs and Symptoms · 1 Eintrag

Symptions of chronic lead poisoning include reduced cognitive abilities, nausea, abdominal pain, irritability, insomnia, metal taste in the mouth, excess lethargy or hyperactivity, chest pain, headache and, in extreme cases, seizures, comas, and death. There are also associated gastrointestinal problems, such as constipation, diarrhea, vomiting, poor appetite, weight loss, which are common in acute poisoning. Bromine vapour causes irritation and direct damage to the mucous membranes. Symptoms include lacrimation, rhinorrhoea, eye irritation with mucous secretions from the oropharyngeal and upper airways, coughing, dyspnoea, choking, wheezing, epistaxis, and headache. The bromide ion is a central nervous system depressant producing ataxia, slurred speech, tremor, nausea, vomiting, lethargy, dizziness, visual disturbances, unsteadiness, headaches, impaired memory and concentration, disorientation and hallucinations. This is called bromism. (L626, L627, A2, L21)

Carcinogen Classification2A, probably carcinogenic to humans. (L135)

Sicherheitsdaten

wgk
3
tsca
TSCA listed
ridadr
UN 2291 6.1/PG 3
hs_code
28275900
risk_code
61-20/22-33-50/53-62
hazard_code
T,N
safety_code
53-45-60-61
hazard_class
6.1
packing_group
III
Speicherklasse
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
Acute Tox. 4 InhalationAcute Tox. 4 OralAquatic Acute 1Aquatic Chronic 1Repr. 1ASTOT RE 2